Multiple antibiotic resistance in Streptococcus pneumoniae

British Medical Bulletin

Volumn 54, Issue 3, 1998, Pages 595-610

  Crook, Derrick W M ^a   Spratt, Brian G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; PENICILLIN G; TETRACYCLINE; VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; HUMAN; IMMUNIZATION; MENINGITIS; MORBIDITY; MORTALITY; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0031752091     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011713     Document Type: Review

References (39)

1. Finland M. Pneumococcal infections. In: Evans AS, Feldman HA. (eds) Bacterial Infections of Humans: Epidemiology and Control. New York: Plenum, 1982; 417-33
2. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96
3. Coffey TJ, Dowson CG, Daniels M, Spratt BG. Genetics and molecular biology of β-lactam-resistant pneumococci. Microb Drug Res 1995; 1: 25-30
4. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997; 24: S85-8
5. Kim SN, Kim SW, Choi IH, Pyo SN, Rhee DK. High incidence of multidrug-resistant Streptococcus pneumoniae in South Korea. Microb Drug Res 1996; 2: 401-6
6. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63
7. Lyon DJ, Scheel O, Fung KSC, Cheng AFB, Henrichsen J. Rapid emergence of penicillin-resistant pneumococci in Hong Kong. Scand J Infect Dis 1996; 28: 375-6
8. McDougal LK, Rasheed JK, Biddle JW, Tenover FC. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob Agents Chemother 1995; 39: 2282-8
9. Barcus VA, Ghanekar K, Yeo M, Coffey TJ, Dowson CG. Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae. FEMS Microbiol Lett 1995; 126: 299-304
10. Coffey TJ, Daniels M, McDougal LK, Dowson CG, Tenover FC, Spratt BG. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to third generation cephalosporins. Antimicrob Agents Chemother 1995; 39: 1306-13
11. Coffey TJ, Dowson CG, Daniels M et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 2255-60
12. Muñoz R, Coffey TJ, Daniels M et al. Intercontinental spread of a multiresisrant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-6
13. Coffey TJ, Berrón S, Daniels M et al. Multiply-antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology 1996; 142: 2747-57
14. Sa Figueiredo AM, Austrian R, Urbaskova P, Teixeira LA, Tomasz A. Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microb Drug Res 1995; 1: 71-8
15. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995; 171: 890-6
16. Coffey TJ, Enright MC, Daniels M et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol 1998; 27: 73-84
17. Reichler MR, Rakovsky J, Sobotova A et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia and meningitis in Slovakia. J Infect Dis 1995; 171: 1491-6
18. Nava JM, Bella F, Garau J et al. Predicative factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19: 884-90
19. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24: 1052-9
20. Anonymous. Defining the public health impact of drug-resistant Streptococcus pneumoniae: Report of a working group. MMWR Morb Mortal Wkly Rep 1996; 45: RR-1
21. Zangwill KM, Vadheim CM, Vannier AM et al. Epidemiology of invasive pneumococcal diseases in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174: 752-9
22. Pallares R, Linares J. Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80
23. McCracken GH. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 1995; 14: 424-8
24. Knudsen JD, Frimodt-Moller N, Espersen F. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 1995; 39: 1253-8
25. Ponte C, Parra A, Nieto E et al. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime and meropenem. Antimicrob Agents Chemother 1996; 40: 2698-702
26. Froom J, Culpepper L, Jacobs M et al. Antimicrobials for otitis media? A review from the international primary care network. BMJ 1997; 315: 98-102
27. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997; 314: 1526-9
28. Gehanno P, Lenoir G, Bercher P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995; 39: 271-2
29. Block SL, Harrison CJ, Hedrick JA et al. Penicillin-resistant Streptocococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14: 751-9
30. Bradley JS, Kaplan SL, Klugman KP et al. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J 1995; 14: 1037-41
31. Klugman KP. The clinical relevance of in vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother 1996; 38: 133-40
32. Paris MM, Ramilo O, Cracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 39: 2171-5
33. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992; 339: 405-8
34. Jacobs RF, Kaplan SL, Schutze GE et al. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrob Agents Chemother 1996; 40: 895-8
35. Viladrich PF, Cabellos C, Pallares R et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 218-20
36. Tan TQ, Schutze GE, Mason EO et al. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1994; 38: 918-23
37. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1988-92
38. Kayhty H, Eskola J. New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis 1996; 2: 289-98
39. Hughes JM, Tenover FC. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations. Clin Infect Dis 1997; 24 (Suppl 1): S131-5